AI is transforming longevity as companies like METiS TechBio and Human Longevity use algorithms to combat ageing and predict ...

A new study developed a mineralized DNA hydrogel that combines immune regulation with sustained bone regeneration. Using ...

LONDON -- In yet another effort to repurpose oncology drugs for autoimmune disease, a researcher reported here that low doses of blinatumomab (Blincyto) given to patients with treatment-resistant ...

The raise signals a pattern among crypto executives channeling wealth into adjacent technology sectors. Armstrong has already ...

NewLimit, which plans to take its young-again cell reprogramming therapy into the clinic next year, raised a $435 million ...

NewLimit Series C raises $435M led by Founders Fund as Armstrong-backed startup moves epigenetic therapies toward human ...

NewLimit is pressing the gas, speeding into clinical trials much sooner than expected after lab research showed its epigenetic reprogramming asset reversed aging in human liver cells. After raising ...

Researchers from the Icahn School of Medicine at Mount Sinai have discovered a promising new way to improve CAR-T cell ...

NewLimit’s lead liver combo has proven its worth in preclinical models, Kimmel told Fierce, with the ability to boost ...

A team led by researcher José Vicente Sánchez Mut at the Institute for Neurosciences (IN), a joint center of the Spanish ...

Medical University of South Carolina (MUSC) researchers have developed an engineered stem cell treatment capable of reversing ...